In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Retroprogesterone, 6-dehydro- Drug Master File in Korea (Retroprogesterone, 6-dehydro- KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Retroprogesterone, 6-dehydro-. The MFDS reviews the Retroprogesterone, 6-dehydro- KDMF as part of the drug registration process and uses the information provided in the Retroprogesterone, 6-dehydro- KDMF to evaluate the safety and efficacy of the drug.
After submitting a Retroprogesterone, 6-dehydro- KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Retroprogesterone, 6-dehydro- API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Retroprogesterone, 6-dehydro- suppliers with KDMF on PharmaCompass.